Corbus Pharmaceuticals Holdings (CRBP) Assets (2013 - 2025)

Corbus Pharmaceuticals Holdings' Assets history runs 13 years deep, the most recent figure standing at $168.2 million for Q4 2025.

• On a quarterly basis, Assets rose 7.9% year-over-year to $168.2 million in Q4 2025; TTM through Dec 2025 was $168.2 million, a 7.9% increase from a year earlier, with the FY2025 full-year figure at $168.2 million, up 7.9% from the prior year.
• Assets improved to $168.2 million in Q4 2025 per CRBP's latest filing, from $109.5 million in the prior quarter.
• Across five years, Assets topped out at $168.2 million in Q4 2025 and bottomed at $28.3 million in Q4 2023.
• The 5-year median for Assets is $114.5 million (2021), against an average of $105.3 million.
• Across the five-year window, Assets slumped 57.37% in 2023 and surged 451.35% in 2024, its largest moves.
• Year by year, Assets stood at $107.7 million in 2021, then plunged by 38.45% to $66.3 million in 2022, then slumped by 57.37% to $28.3 million in 2023, then jumped by 451.35% to $155.9 million in 2024, then increased by 7.9% to $168.2 million in 2025.
• Per Business Quant, the three latest CRBP Assets figures stand at $168.2 million (Q4 2025), $109.5 million (Q3 2025), and $125.1 million (Q2 2025).